Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology

R E Kibbelaar, B E Oortgiesen, A M van der Wal-Oost, K Boslooper, J W Coebergh, N J G M Veeger, P Joosten, H Storm, E N van Roon, M Hoogendoorn

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

Randomised clinical trials (RCTs) are considered the basis of evidence-based medicine. It is recognised more and more that application of RCT results in daily practice of clinical decision-making is limited because the RCT world does not correspond with the clinical real world. Recent strategies aiming at substitution of RCT databases by improved population-based registries (PBRs) or by improved electronic health record (EHR) systems to provide significant data for clinical science are discussed. A novel approach exemplified by the HemoBase haemato-oncology project is presented. In this approach, a PBR is combined with an advanced EHR, providing high-quality data for observational studies and support of best practice development. This PBR + EHR approach opens a perspective on randomised registry trials.

Original languageEnglish
Pages (from-to)178-185
Number of pages8
JournalEuropean Journal of Cancer
Volume86
DOIs
Publication statusPublished - Nov-2017

Keywords

  • Electronic health record
  • Population-based registry
  • Randomised clinical trial
  • Evidence-based medicine
  • Haematology
  • Oncology
  • B-CELL LYMPHOMA
  • NETHERLANDS CANCER REGISTRY
  • MULTIPLE-MYELOMA PATIENTS
  • HEMATOLOGICAL MALIGNANCIES
  • PHAROS-REGISTRY
  • INFERENTIAL GAP
  • PUBLIC-HEALTH
  • SURVIVAL
  • EUROPE
  • DISEASE

Cite this